Zimmer Biomet Holdings, Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.7B 1.8B 1.6B 1.7B
Cost of revenue 476.4M 504.4M 468.3M 499.7M
Gross profit 1.2B 1.3B 1.2B 1.2B
Operating expense
Research & development 98.7M 96.5M 94.2M 92.4M
Selling general and admin 691.1M 694.0M 646.3M 636.2M
Other operating expenses
Operating income 288.2M 337.6M 288.7M 360.7M
Non operating interest income
Income
Expense 64.2M 67.5M 56.4M 52.7M
Other income expense 13.9M -78.8M -37.2M -61.9M
Pretax income 237.8M 191.3M 195.1M 246.2M
Tax provision 40.9M 60.6M 39.6M 41.7M
Net income 196.9M 130.7M 155.5M 204.5M
Basic EPS 0.8 0.9 1.2
Diluted EPS 0.8 0.9 1.2
Basic average shares 168.6M 169.4M 169.6M
Diluted average shares 168.9M 170.1M 170.3M
EBITDA 532.5M 572.5M 507.8M 552.9M
Net income from continuing op. 196.9M 130.7M 155.5M 204.5M
Minority interests -255.5K -511.1K -511.1K -596.2K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 45 minutes

05:14
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).